Long-term Effect of Plasmin on the Vitreolysis in Rabbit Eyes.
Nam Ju Kim, Hyeong Gon Yu, Young Suk Yu, Hum Chung
Korean J Ophthalmol. 2004;18(1):35-40.   Published online 2004 Jun 30     DOI: https://doi.org/10.3341/kjo.2004.18.1.35
Citations to this article as recorded by Crossref logo
Nicolas A. Yannuzzi, Natalia F. Callaway, Jayanth Sridhar, William E. Smiddy
Retina.2018; 38(10): 2081.     CrossRef
Pharmacologic Vitreolysis with Ocriplasmin: Rationale for Use and Therapeutic Potential in Vitreo-Retinal Disorders
Matin Khoshnevis, J Sebag
BioDrugs.2015; 29(2): 103.     CrossRef
Ocriplasmin for Vitreoretinal Diseases
Irena Tsui, Carolyn K. Pan, Ehsan Rahimy, Steven D. Schwartz
Journal of Biomedicine and Biotechnology.2012; 2012: 1.     CrossRef
Efficacy of Autologous Plasmin-Assisted Vitrectomy for Rhegmatogenous Retinal Detachment
Chaerin Park, Sun Ho Lee, Jang Won Heo, Hum Chung
Journal of the Korean Ophthalmological Society.2011; 52(7): 825.     CrossRef
Efficacy of Plasmin, Microplasmin, and Streptokinase-Plasmin Complex for theIn VitroDegradation of Fibronectin and Laminin- Implications for Vitreoretinal Surgery
M. Hermel, W. Dailey, M. K. Hartzer
Current Eye Research.2010; 35(5): 419.     CrossRef
Comparison of Vitreolytic Effect in Rabbit Eyes: Plasmin, Hyaluronidase, and Their Mixtures
Moo Sang Kim, Sang Woong Moon, Eung Suk Kim, Seung Young Yu, Hyung Woo Kwak
Journal of the Korean Ophthalmological Society.2009; 50(6): 911.     CrossRef
Nonclinical Safety and Pharmacokinetics of Intravitreally Administered Human-Derived Plasmin in Rabbits and Minipigs
Joel W. Proksch, Jean-Yves Driot, Pete Vandeberg, Keith W. Ward
Journal of Ocular Pharmacology and Therapeutics.2008; 24(3): 320.     CrossRef
The Structure of the Internal Limiting Membrane Removed by Vitrectomy Using Tissue Plasminogen Activator
Dong Su Kim, Sang Woong Moon, Seung Young Yu, Hyung Woo Kwak
Journal of the Korean Ophthalmological Society.2008; 49(6): 917.     CrossRef
Current and future pharmacological intervention for diabetic retinopathy
Grant M Comer, Thomas A Ciulla
Expert Opinion on Emerging Drugs.2005; 10(2): 441.     CrossRef